Dowling & Yahnke’s Eastman Chemical EMN Stock Holding History

Dowling & Yahnke’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,807	Closed	-$218K	–	381
2021 Q4	$218K	Buy	+1,807	New	+$201K	0.01%	361
2021 Q3	–	Sell	-1,807	Closed	-$211K	–	375
2021 Q2	$211K	Sell	1,807 -45	-2%	-$5.4K	0.01%	349
2021 Q1	$204K	Buy	+1,852	New	+$201K	0.01%	325

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dowling & Yahnke's EMN Position: Q1 2022 in Review

Dowling & Yahnke sold out of Eastman Chemical (EMN) in Q1 2022, closing a stake of 1,807 shares — an estimated $218K sold.

Dowling & Yahnke first reported a position in EMN in Q1 2021 and held it in 3 quarters. The position peaked at $218K in Q4 2021. 751 funds tracked by Wall St. Rank hold EMN as of Q1 2022.

Dowling & Yahnke reported no remaining Eastman Chemical position as of Q1 2022 after selling out during the quarter.
Dowling & Yahnke sold 1,807 Eastman Chemical shares in Q1 2022, an estimated $218K.
Dowling & Yahnke first reported a position in Eastman Chemical in Q1 2021 and held it in 3 quarters.
Dowling & Yahnke's Eastman Chemical position peaked at $218K in Q4 2021.
751 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2022.

Based on Dowling & Yahnke's 13F filing for Q1 2022, filed 4 May 2022.